热门资讯> 正文

Jade Biosciences计划公开发行预融资认购证

2026-06-04 04:26

JPMorgan发展中市场股票主动型ETF(JADE) 0

Jade Biosciences (JBIO) on Wednesday said it intends to offer shares of common stock and, in lieu of common stock for certain investors, pre-funded warrants in an underwritten public offering.
The company also plans to grant underwriters a 30-day option to purchase up to an additional 15% of the securities offered.
Proceeds will be used to support clinical trials, preclinical studies, manufacturing, research and development activities, and general corporate purposes.
Shares down 3% in after-hours trading.

More on Jade Biosciences, Inc.

Jade Biosciences: Strong Early Signal, But Still A Wait For Proof
Jade Biosciences, Inc. (JBIO) Discusses Positive Interim Results From JADE101 Phase I Healthy Volunteer Study and Development Plans Transcript
Jade Biosciences: Caution Advised Before Clinical Trial Results
Seeking Alpha’s Quant Rating on Jade Biosciences, Inc.
Historical earnings data for Jade Biosciences, Inc.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。